| Names | |
|---|---|
| Preferred IUPAC name | calcium 3-({[(2R)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino}propanoate) |
| Other names | Pantothenic acid Vitamin B5 Dexpanthenol Pantothenate |
| Pronunciation | /ˈkæl.si.əm pænˈθəʊ.ˌneɪt/ |
| Identifiers | |
| CAS Number | 137-08-6 |
| Beilstein Reference | 1105009 |
| ChEBI | CHEBI:31346 |
| ChEMBL | CHEMBL1201210 |
| ChemSpider | 36361 |
| DrugBank | DB03404 |
| ECHA InfoCard | ECHA InfoCard: 100.028.278 |
| EC Number | EC 3.1.1.31 |
| Gmelin Reference | 63629 |
| KEGG | C00712 |
| MeSH | D017325 |
| PubChem CID | 11797611 |
| RTECS number | SD6800000 |
| UNII | 8M6LZQ43LU |
| UN number | UN Not Regulated |
| Properties | |
| Chemical formula | C18H32CaN2O10 |
| Molar mass | 476.5 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 0.45 g/cm³ |
| Solubility in water | Freely soluble in water |
| log P | -4.0 |
| Vapor pressure | Negligible |
| Acidity (pKa) | 8.4 |
| Basicity (pKb) | 8.38 |
| Magnetic susceptibility (χ) | -7.9e-6 |
| Refractive index (nD) | 1.555 |
| Dipole moment | 0 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 576.8 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -1616.3 kJ/mol |
| Pharmacology | |
| ATC code | A11HA03 |
| Hazards | |
| Main hazards | May cause eye, skin, and respiratory tract irritation. |
| GHS labelling | GHS labelling: Not a hazardous substance or mixture according to the Globally Harmonized System (GHS). |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | Hazard statements: May cause respiratory irritation. |
| Lethal dose or concentration | LD50 (oral, rat): >10,000 mg/kg |
| LD50 (median dose) | LD50 (median dose) of Calcium Pantothenate: "10,000 mg/kg (oral, rat) |
| NIOSH | NO DATA |
| PEL (Permissible) | 10 mg/m³ |
| REL (Recommended) | 5-10 mg |
| IDLH (Immediate danger) | Not listed |
| Related compounds | |
| Related compounds | Pantothenic acid Dexpanthenol Calcium phosphate Magnesium pantothenate Sodium pantothenate |
| Attribute | Manufacturer Commentary |
|---|---|
| Product Name | Calcium Pantothenate |
| IUPAC Name | Calcium (R)-2,4-dihydroxy-3,3-dimethylbutanamido]propanoate |
| Chemical Formula | C18H32CaN2O10 (represents the calcium salt of pantothenic acid in hydrated or anhydrous form, formulation and batch water content may influence the calculated formula on documentation) |
| Synonyms & Trade Names | D-Calcium pantothenate, Pantothenic acid calcium salt, Vitamin B5 (calcium salt), Vitamin B5 Ca |
| HS Code & Customs Classification | Typical customs classification uses HS Code 2936.27 (Vitamins and their derivatives, unmixed), but regional sub-codes or additional digits apply depending on formulation (feed grade, food grade, pharmaceutical grade) and jurisdictional import restrictions. For industrial shipments, correct code selection follows intended end-use and regional authority guidance. Manufacturers submit supporting technical descriptions during customs clearance to demonstrate product type and grade. |
Pantothenic acid synthesis and calcium salt formation utilize route selection guided by available raw material quality and final impurity targets. Calcium sources are assessed for trace metal profile and soluble contaminant burden rather than nominal purity alone since certain trace elements can impact subsequent formulation stability or contribute to out-of-specification results during batch release. The amide intermediate stage in pantothenate synthesis can generate process-specific impurities driven by upstream catalytic system and solvent residue profile. Food, feed, and pharma grades diverge early in the production chain: only premium, validated supply chains qualify for pharmaceutical manufacturing lines.
Batch consistency forms the foundation of downstream manufacturing reliability. Process engineers monitor intermediate conversion efficiency—especially where temperature, pH, and solvent content influence crystallization kinetics or hydrate formation state. Depending on product grade, the point of calcium salt addition and subsequent filtration or recrystallization steps adapts to either maximize purity (pharma/food grade) or throughput (feed/technical grade). In-process controls track total organic volatile content and residual catalyst or heavy metals, with test frequencies set in response to batch performance trends and qualification requirements.
In industrial practice, Calcium Pantothenate typically presents as a white, odorless, and almost tasteless powder. Moisture content, particle size, and bulk density depend on mechanical drying and milling steps, with tighter controls for food/pharma lines. Downstream performance in premix or tablet formulation requires robust particle flow and low caking tendency, which ties directly to water activity and surface charge—the latter influenced by both manufacturing route and optional antistatic agent use. Animal feed and bulk fortification grades shift toward higher allowable moisture or broader sieve fraction, as end-use application tolerates more variability.
Impurity management draws attention to solvent carryover, side-reaction byproducts, and trace element content throughout synthesis and salting-out stages. Purification choices weigh the regulatory threshold of the intended market. For pharmaceutical lines, multi-stage recrystallization followed by pressure filtration ensures sub-ppm levels for regulated impurities, with real-time analytics supporting in-process troubleshooting. Feed and technical grades will skip certain expensive purification steps but still track bulk contaminants to guard against physical hazards and avoid non-compliance on shipment.
HS Code declarations reflect not only the chemical structure but also the certified use of the delivered product. Misclassification risks customs hold-ups and regulatory queries, which add burden on inventory storage and cold-chain if applicable. Grade-specific supporting documentation—certificate of analysis, statement of intended use, and grade release specification—reinforces the customs compliance process. Manufacturer teams prepare technical evidence packages to clarify any ambiguity during international shipment, especially in jurisdictions with heightened scrutiny on vitamin additives and fortification ingredients.
Production-grade calcium pantothenate generally presents as a white to off-white, odorless powder. The exact hue and morphology may depend on the synthesis route, drying method, and grade. Powder flowability and particle size distribution frequently exhibit sensitivity to crystallization and granulation steps in large-scale manufacturing. Suppliers for tableting grades optimize physical form and particle size to minimize dust and support uniform blending.
Melting and decomposition characteristics vary by impurities and hydration state. Direct measurement typically guides process troubleshooting if batch consistency shifts. Densities are monitored during intermediate storage and bulk packing to control fill weights and avoid caking or bridging.
Stability depends on product humidity, pH of surrounding materials, and exposure to oxidizing or reducing agents. This compound shows sensitivity to acids and alkalis above certain concentrations and decomposes at elevated temperatures. Regular monitoring identifies deviation in typical batch stability profiles, which may arise from altered raw material quality or insufficient drying.
Solubility lies in the moderate-to-high range in water and is grade dependent. Solubility in organic solvents is limited. Accurate solution preparation for formulation and analytical use relies on fresh dissolution, temperature control, and gentle agitation to minimize hydrolysis or precipitation, particularly where low-residue or injectable grades are required.
Industrial, food, and pharmaceutical grades differ across assay, moisture, and impurity limits, often reflecting downstream user requirements. Typical values depend on grade and customer registration status. The final release standard is subject to internal quality control criteria and customer requirements.
Impurities come from starting material selection, reaction side-products, and equipment residues. The profile and control limits are stricter for parenteral and veterinary applications versus feed or technical grade. Quality teams routinely monitor boron, heavy metals, and specific organic impurities based on intended market and regulatory demand, modifying control points as needed if upstream sources shift.
Testing aligns with regional pharmacopeias, food safety directives, and customer-agreed protocols. Typical methods include high-performance liquid chromatography and loss on drying. The selection of reference standards and method validation is reviewed as raw material origins and batch scale evolve.
Ascorbic acid, D-pantoic acid, and β-alanine serve as principal reagents, with calcium salts introduced for complexation and precipitation. Suppliers are qualified on trace impurity content, consistency, and supply reliability. Shifts in raw material quality often drive investigation into resultant impurity spikes or physical property shifts in the finished product.
Commercial processes commonly use a condensation of D-pantoic acid with β-alanine, followed by reaction with calcium salt to produce the stable calcium form. Process selection reflects feedstock economics, impurity minimization, and environmental compliance at the production site.
Key control points include pH, reaction time, and temperature during condensation and precipitation. Continuous filtration and controlled drying remove unreacted intermediates and byproducts. Process tracking systems document the deviation from target conditions to enable root-cause analysis when batch variability arises.
Analytical verification ensures target assay, impurity levels, moisture content, and particle form. Batches with non-conformance in critical quality attributes are segregated and investigated. Release criteria follow both regulatory and internal quality standards, with additional customer-specific tests as negotiated.
The molecule may undergo hydrolysis under acidic or basic conditions, resulting in conversion to pantothenic acid and related breakdown products. Mild oxidizing or reducing environments can generate impurities that affect grade qualification for certain end uses.
Reaction rates and yields in the main synthetic route stem from temperature, solvent volume, and purity of reactants. Extreme pH and high temperatures degrade both intermediate and final product, which restricts the use of aggressive purification technologies in downstream processing.
Derivative formation focuses on pantothenic acid esters and specialty salt forms for custom formulation. These modifications depend on downstream application requirements and drive the demand for tighter impurity and origin control.
Bulk storage uses sealed, light-protected, food-grade or pharmaceutical-grade containers. Absorption of moisture, direct light exposure, and residual atmospheric oxygen contribute to loss of potency and visible yellowing or caking. Most sites implement controlled temperature and humidity environments for packaging and long-term warehousing.
Manufacturers standardize on inert, moisture-barrier containers compatible with the grade produced. Reactive metals and some plastics can contribute leachables or discoloration, so rigorous compatibility testing supports packaging transitions.
Shelf life claims respond to controlled stability data under defined storage conditions. Degradation typically reveals itself as potency reduction, off-odor, color change, or impaired solubility. Ongoing batch stability tracking guides retention policy and customer notification if accelerated degradation is seen.
Hazard classification may vary based on country and grade but generally assigns minimal acute health hazard under normal handling conditions. Sensitization, irritation, or environmental hazard ratings are determined by current toxicological reviews and customer use scenarios.
Labeling aligns with regional GHS interpretations and on-site risk assessment. Requirements reflect both chronic exposure studies and formulated product end use, especially in nutraceutical and pharmaceutical grades.
No significant acute systemic toxicity has been demonstrated at industry-relevant exposure levels, though local irritation may occur in dusty or high-volume production environments. Longer-term reviews assess any risk from trace impurities unique to synthetic route or raw material origin.
Workplace exposure control uses dust suppression, local exhaust ventilation, and personal protective equipment, with thresholds determined by occupational hygiene data. Spill clean-up, transfer, and sampling procedures are reviewed regularly to address any change in packaging format, batch size, or material form.
Manufacturing calcium pantothenate relies on raw material throughput, reaction control, purification, and packaging line uptime. Year-round output shows cyclical impacts from upstream fermentation substrate costs and workforce deployment, especially during local holiday periods. Plant utilization fluctuates with maintenance cycles and energy supply disruptions, particularly in regions heavily dependent on grid reliability. Production capacity varies by grade (food, pharma, feed), with pharma-grade typically requiring longer plant occupation due to more involved purification and release testing. Realistic annual availability must factor in contractual allocations to core accounts, leaving spot supply subject to deviation based on customer qualification and market shifts.
Lead times reflect batch queueing protocols, grade-specific release assays, and required documentation. Pharma and infant nutrition grades usually involve test waits for heavy metals, solvent residues, and microbial profile. Minimum order quantity depends on downstream blending batch sizes and customer repack needs; industrial feed grade generally ships in larger units, while pharma grade often requires smaller lots per validated batch. Lead time shortens if forecast alignment exists or rolling contracts secure capacity, while spot purchasers face lead times limited by current batch output and order volume.
Packaging adapts to grade and market: food and pharma grades use lined fiber drums or PE-foil composite to limit moisture exposure and cross-contamination risks. Feed grade typically moves in solid PE bags or super sacks, balancing weight with pallet handling constraints. Export packaging must address storage duration, climate, and seal integrity for extended ocean transit. Certification for migration tests and trace component leaching applies to high-purity end-uses.
Shipping terms closely track buyer risk tolerance, transit time, and insurance needs. Most high-purity grades ship under CIF or DAP for international buyers, with local customers often preferring ex-works pickup. Payment typically hinges on buyer credit rating, contract length, and proof of regulatory clearance. For new markets or first-time buyers, advance TT or documentary LC remains common. Established accounts may access 30- or 60-day post-invoice terms, subject to credit review. Logistic disruptions and new export restrictions may drive up container costs or trigger split shipments, with all-in costs tied closely to global freight indices.
Pantothenic acid synthesis starts with keto-isovalerate and various alcohol precursors, a process vulnerable to fluctuating feedstock and solvent market prices. Intermediates sourced from petrochemical streams, fermentation broth, and sometimes plant extraction will show region-specific price sensitivity to oil, maize, or sugarcane pricing. Catalyst, energy, and purification solvent expenses rise under volatile global energy conditions. Final API or food-grade cost structures layer in batch release testing, GMP document requirements, packaging neutralization, and multi-modal logistics.
Price swings tie back to two main triggers: upstream cost pressure (keto-acid, solvents, labor, utilities) and shifts in regulatory or environmental compliance impacting plant throughput or product yield. Supply chain interruptions—especially with increased scrutiny on solvent emissions and waste disposal—may temporarily lower output or require expensive process changes, directly impacting manufacturing cost per unit across all grades.
Grade purity drives the core price gap. Pharma and infant nutrition grades require additional purification, tighter batch segregation, and validated absence of defined impurities, substantially increasing the cost versus technical or feed grade. For certain markets, religious or organic certifications add further batch controls and documentation costs. Packaging certification also affects final price, with migration-tested packaging and tamper-evident seals needed in food and pharma channels. Regional traceability, serialization, and new anti-counterfeiting mandates for pharma supply chains add another layer to pricing.
China and India dominate global output, providing low-cost feed and technical grades. Western pharma and food accounts balance imports with limited domestic capacity from established specialty players. Rapid volume swings in animal nutrition, functional foods, and supplements drive short-term demand spikes, causing periodic price volatility when upstream constraints or regulatory bottlenecks hit. Inventory cycles, regulatory re-inspections, and shifts in health supplement legislation affect demand by geography.
| Region | Production Notes | Key Demand Drivers | Regulatory Environment |
|---|---|---|---|
| US | Minimal local manufacture; dependent on imports for pharma & food | Supplement and fortified food market; animal nutrition | cGMP critical, DSHEA and FSMA compliance required |
| EU | Smaller volume, specialized pharma-grade sites; major imports | Medical nutrition, food supplement, strict pharma uses | EFSA, REACH, FAMI-QS for feed |
| JP | Limited specialty grade production; close oversight of imports | Fortified foods, pharma, infant formula | PMDA and Food Sanitation regime apply |
| IN | Large-volume technical and feed grades | Direct use and re-export; food and nutraceuticals | FSSAI and CDSCO regulation |
| CN | World's largest producer, all major grades | Local and global supply, price leader, all applications | Strong environmental controls tightening since 2022 |
By 2026, pricing will reflect ongoing environmental regulation changes in China, variable energy prices, and potential tariff fluctuations from evolving international trade policy. Pharma and food grade prices are expected to show moderate long-term growth due to higher compliance burden and batch traceability investments. Feed and technical grades will track more closely to bulk chemical index and cargo freight rates. Rapid expansion of fortified food and supplement segments across Asia-Pacific may strain spot capacity and drive short-term spikes. Customers securing long-term contracts with QA audits likely gain more stable pricing.
Price and market position based on internal order volumes, customer contract reviews, independent market reports (Food Chemicals Codex, ICIS), and public regulatory filings. Data cross-referenced with quarterly plant throughput records and selected import/export ledger analysis.
Recent quarters brought periodic feedstock interruptions and tighter environmental inspections at Asian production hubs, causing temporary factory slowdowns. Global freight costs remained volatile post-pandemic, pushing up delivered cost per MT. New projects in Southeast Asia seek to expand non-China supply base but currently cover low single-digit market share.
Major markets updated requirements for residual solvent testing and batch-level trace impurities, raising bar for supply to infant and pharma applications. China increased frequency and depth of plant environmental inspections, prompting investment in solvent recovery and emissions control upgrades. Exporters to the EU face new scrutiny under REACH/CLP updates, particularly on allergen and migration certification in food products.
To address regulatory shifts, our team expanded in-process analytical checkpoints, increased investment in automation for batch segregation, and updated batch documentation systems to shorten QA/QC cycle. Sourcing flexibility and redundant inventory pools near ports minimize customer disruption from ocean freight delays. Ongoing process improvements target solvent and water use reduction, aiming to preempt next round of environmental mandates.
Calcium pantothenate finds core use across nutritional, pharmaceutical, feed, and personal care manufacturing. In our facilities, the production team manages dedicated process lines according to the grade destined for each sector.
| Grade | Typical Application | Form & Key Focus |
|---|---|---|
| USP/BP/EP Compliant | Pharma, infant nutrition, adult supplements | Powder; regulatory traceability, low heavy metals |
| Food Grade | General food fortification | Granular/Fine powder; solubility, absence of off-notes |
| Feed Grade | Poultry, livestock, fisheries | Granular/powder; bulk handling and micro-dosing |
| Cosmetic Grade | Lotions, serums, haircare | Fine powder; color/odor specification, allergen risk management |
Each grade is engineered according to sector demand. For end uses tied to regulatory scrutiny, such as pharmaceutical or infant-grade products, only grades manufactured under validated cGMP protocols should be considered. For industrial blends or non-critical applications, functional attributes such as powder flow and handling may take priority over analytical purity.
Strict alignment with local and export standards forms the foundation of our batch-release philosophy. For pharmaceutical and baby nutrition markets, production teams document all primary materials and validate process controls to meet USP, EP, or BP documentation. Food and feed sectors may operate with broader specification ranges, but allergen and contaminant lists are benchmarked regularly.
Purity varies by grade and impacts both safety and downstream process yield. Feed applications tolerate broader impurity distributions compared to active pharmaceutical ingredients. Our QC labs use HPLC and mass spectrometry for defining grade-specific acceptance windows outlined in contractual commitments or pharmacopeial monographs.
Production volume and budget directly influence granularity of quality requirements. High-volume feed operations often select grades packed for efficient handling, where micronutrient balance and stability outpace absolute purity. Smaller scale or critical ingredients for pediatric formulas necessitate granular traceability and tighter batch acceptance windows, with higher associated cost per kilo.
Sourcing departments and formulation chemists gain confidence through sample validation. We encourage analytical and application-specific checks, such as dissolution testing and organoleptic assessment, before final grade adoption. Our technical support addresses process-fit, addresses potential for cross-contamination, and provides document traceability down to raw material batch.
As a manufacturer with in-house synthesis, our calcium pantothenate operations maintain compliance with established quality management systems. Certification under international standards—such as ISO 9001—arises from an approach built around traceable batch records, equipment qualification protocols, and robust change management procedures. Certification scope includes oversight spanning raw material vendor qualification, cross-referenced batch tracking, deviation handling, and corrective action closure with documentary evidence.
Batch-to-batch process control and continuous improvement plans are regularly audited both internally and by accredited third parties. Operator training, metrology checks, and preventative maintenance schemes are carried out according to a schedule aligned with certification renewal and surveillance audit cycles. Certification status may differ based on the physical manufacturing location or final product grade, so formal evidence is available on request.
Calcium pantothenate grades—whether for food, feed, or pharmaceutical ingredients—are subject to application-dependent certification schemes. Purity specifications, permissible impurity limits, and applicable monographs vary between grades destined for human or animal use. Product batches designated for regulated applications can be supported by Kosher, Halal, or non-GMO declarations only after full traceability and process verification. Pharmaceutical grades align with pharmacopoeial requirements when specified by the customer and supported by validated analytical data.
Standard documentation supplied with each shipment includes Certificate of Analysis (COA) based on actual batch release data and method references. Detailed batch records, audit reports, or certificates of origin can be supplied for grade-specific or regulatory-driven orders. Change notifications or deviations are reported transparently if impacting specification, compliance, or performance. Custom documentation—such as stability statements, allergen declarations, or supply chain certifications—are prepared in line with customer or market requirements, provided valid disclosure channels and supply infrastructure are present.
Production capacity for calcium pantothenate is drawn from core automated synthesis lines using vetted raw materials and strict process scheduling. Emergency inventory buffers and shift-pattern adjustments mitigate supply interruptions. Supply commitments can be secured through rolling forecast agreements or spot orders with lead time guidance, tailored to customers with steady or variable demand patterns. Cooperation schemes—ranging from annual contracting to flexible allocation—are negotiated based on application segment and forecast reliability, always grounded in practical supply capabilities.
Plant output is planned via back-integration of key intermediates and source qualification of supply-sensitive raw materials. Grade allocation depends on downstream validation cycles, trace impurity removal, and blending consistency for nutritional or pharma grades. Multiple synthesis reactors and on-site packaging ensure continuity through demand surges, with real-time capacity monitoring and escalation protocols for process deviations. Long-term reliability stems from in-house utilities management, upstream risk mapping, and prompt secondary sourcing for critical materials.
Sample requests proceed via technical review of intended use, expected volume, and specification needs. Representative batch samples are selected based on grade, application, and analytical data matching the target profile. Documentation follows shipment including production date, tested parameters, and reference methods. Special handling or additional reports—such as residual solvent profiles or customized packaging—depend on customer dossier requirements and regulatory jurisdiction.
Flexible cooperation extends to toll manufacturing agreements, custom batch segregation, and adjusted labelling or documentation for private brand orders. Minimum order quantities, release frequency, and pricing structure can be adapted for clients with cyclical or project-based consumption. Lot allocation systems accommodate split shipments and just-in-time delivery; multi-site distribution is managed via synchronized logistics and digital tracking. Special handling and documentation for export controls, restricted substances, or specific market access are available provided advanced notice matches the operational cycle of qualified manufacturing and quality release.
Research efforts around Calcium Pantothenate often converge on improving bioavailability and establishing efficient synthesis pathways with minimal impurity profiles. Interest has grown in process intensification, including reaction route optimization that lowers byproduct formation. In the production department, batch consistency and impurity management drive nearly every trial. The technical team examines new routes to increase throughput without increasing hydrolysis byproducts or compromising release purity, as nutraceutical and pharmaceutical customers set increasingly tight cumulative impurity thresholds. Dairy and feed application groups watch for particle size control improvements to reduce agglomeration during blending and ensure optimum dispersibility.
Formulators in consumer health, animal nutrition, and food fortification have started pushing for calcium pantothenate in forms aligned with specialized delivery systems, such as microencapsulation or rapid-release powder blends. This demand puts pressure on compounders to maintain stability in finished products exposed to fluctuating humidity or temperature across extended storage periods typical for global logistics. Animal nutrition sectors focus on customized particle fineness and dust control, since standard powder grades may not suit automated mixing or high-precision micro-dosing lines.
Industrial-scale production faces predictable challenges from raw material input variability and reaction step selectivity. Supply experiences swings in intermediate purity, so process technicians actively adjust pH control and solvent ratios to hit target distributions. Recent improvements in real-time analytical feedback have reduced batch deviation and tightened control of chiral purity. Waste minimization, solvent recycling, and tighter water management have reduced the ecological load, but require ongoing retraining in the operations team and regular reviews by QC supervisors. The main technical breakthrough has come from continuous reaction technology, which improves yield predictability and enables more responsive corrective action compared to batch processes.
The application landscape expects stable growth as regulatory approvals diversify, especially in fortified foods, personal care, and specialty feed. Customers in regulated markets will expect full traceability on all input streams and supply chain records. Industrial buyers align final acceptance criteria with their specific downstream process tolerances, especially as customized blends and delivery formats continue to differentiate product lines. Demand for granular and sustained-release forms is expected to increase. Industrial channels may see stronger scrutiny on the presence and reporting of even low-level side products or polymorphic content.
Continuous process adoption is anticipated to gain traction due to consistent product quality and operational cost optimization. Automated analytics for real-time process monitoring are under pilot testing in several production lines, making specification drift less frequent. Digitalization drives both QC and traceability systems; every update in process control now generates a full audit trail that customers, especially in the pharma segment, increasingly require for vendor qualification.
Manufacturing departments now draw up process adjustment plans focused on energy use and solvent recycling as part of internal audit preparation. Sourcing raw materials from renewable supply chains remains under periodic review but is not universally available, especially for specialty intermediates. Developers invest effort in modular production lines that allow batch size and chemistry route changes with minimal cleaning cycles, reducing overall water and cleaning agent usage. Wastewater treatment now typically includes in-line pH adjustment and solvent recovery, preventing unwanted release into municipal systems. Implementation timelines vary by facility and region.
Application engineers provide direct formulation advice for customers looking to optimize dispersion and stability in their finished goods. Plant managers are available to discuss process parameters, application-specific grade customizations, and compatibility with regulatory expectations in key export regions. Researchers regularly liaise with customers’ R&D teams for early-stage product development trials, supporting technical data delivery for new regulatory submissions or process validations.
Support teams review downstream processes, particularly for clients experiencing variable dissolution rates or reactivity in blends. Technical staff collaborate to troubleshoot flow behavior during tableting or powder mixing, sometimes recommending grade changes or production adjustments to address clumping or caking in humid environments. Class-leading customers often request co-development projects for process-risk assessment and optimization across the product life cycle.
After shipment, service teams coordinate with clients on batch release documentation and provide feedback channels for any field performance anomalies, including appearance change, particle separation, or packaging integrity. Each complaint or deviation triggers a full root-cause investigation from both the QA and production teams. Replacement supply or process re-qualification is managed case by case, according to the outcome of the technical investigation and the nature of customer requirements. Record keeping for each product lot ensures accountability and full traceability for every critical raw material and processing step used.
At our facility, Calcium Pantothenate production draws on years of process refinement. We operate dedicated lines that complete the entire synthesis, crystallization, filtration, and drying sequence in-house. Every step remains tightly controlled, from handling key intermediates through to final packaging. Laboratory teams monitor product features batch-by-batch, verifying precise assay, clarity, moisture, and residual solvent levels.
Demand for Calcium Pantothenate continues to come from several sectors. Food fortification projects, premix blenders, animal nutrition formulators, and dietary supplement brands each set their own technical expectations. Our customers often require ingredient compatibility that supports stability and performance within feed and food applications under variable downstream processing conditions. In industrial vitamin premixes and complex blends, ingredient interaction can dictate the need for tighter impurity profiles or stricter mesh size distribution, which has influenced some of the continuous improvements on our lines.
Maintaining traceable, reproducible output has guided investment in control systems throughout our Calcium Pantothenate lines. Batch records track critical process parameters. Analytical validation draws on HPLC, UV, and micro-testing. Each drum or carton ties to production documentation and retains test records for several years. Our internal requirements often exceed typical food and feed codex standards. Ongoing proficiency checks and thorough supplier qualification for all starting materials help assure predictable lot-to-lot performance at scale.
Calcium Pantothenate order quantities fluctuate based on market cycles and client projects. We support bulk drum packaging, intermediate flexible containers, and smaller cartons, each sealed with tamper-evident systems to safeguard product through transit and storage. Palletization follows international standards and matches customer handling preferences. Our logistics infrastructure supports both full-container and smaller shipment volumes. Lead times stay short, backed by in-house inventory and tested delivery routes.
Integration into manufacturing lines often raises technical questions about solubility under certain pH ranges, miscibility with specific excipients, or interaction during granulation. Factory engineers and chemists provide firsthand guidance based on real plant data and historical sample analysis. Problem-solving does not stop after delivery: customers benefit from troubleshooting, reformulation support, and method sharing based on our direct manufacturing expertise.
Controlling production ensures buyers can secure a stable, directly traceable supply. By managing each operation under one roof, we respond quickly to specification changes, unusual volume requests, or documentation needs driven by audits and new product launches. Procurement teams gain cost predictability without multi-tier markups or loss of transparency over real origin and batch history. Commercial partnership means both manufacturing and distribution teams on the customer side gain timely access to technical backup and quality records, streamlining qualification and reducing operational risk.
| Manufacturing Control | Industrial Application | Quality Consistency | Packaging Range | Technical Support |
|---|---|---|---|---|
| End-to-end process managed by factory specialists | Feed, food, supplement, and premix sectors | Comprehensive batch analysis and retention | Bulk drums, flexible containers, cartons | Direct troubleshooting and formulation advice |
Our experience producing Calcium Pantothenate at an industrial scale has shaped our strict approach to assay control and impurity monitoring. Customers in nutrition, pharmaceuticals, and animal feed consistently request clarity on the purity ranges and impurity controls that we apply in our bulk deliveries. We design our batch releases and shipment testing to meet the requirements defined in leading monographs such as the USP, EP, and JP, which have shaped expectations across global markets.
Calcium Pantothenate in our bulk shipments typically achieves assay values between 98.0% and 102.0% calculated on a dried basis, measured by HPLC or titration in line with pharmacopoeial standards. This specific range ensures compliance with the official reference books used worldwide, but more importantly, it reflects our process control. Across multiple production runs, our in-house laboratory records have shown consistent assay values right within this window. Each batch features a full Certificate of Analysis, with analytical data generated from trained chemists operating validated instrumentation.
Aside from maintaining target assay, monitoring trace impurities is just as critical. The main focus involves controlling related substances such as D-pantolactone, pantoyl lactone, and any degradation products. Our impurity profiles are regularly benchmarked to meet or surpass global pharmacopoeial specifications, setting maximum allowable levels for individual related compounds and for total impurities. For typical batches, individual impurities fall below 0.1%, with total related impurities regularly testing below 0.5%. The main route for by-products in Calcium Pantothenate manufacture comes from incomplete reactions or decomposition under heat; we address this by fine-tuning our process conditions and purification steps.
Inorganic impurities such as heavy metals and residual solvents attract just as much scrutiny. We apply routine analysis for heavy metals (including lead and arsenic) as outlined in relevant regulatory frameworks. Through decades of process improvement, we have achieved results for heavy metals consistently below 10 ppm, often significantly lower. We do not use chlorinated solvents in any production step, and our quality records show non-detectable levels of typical residual solvents in routine HPLC-GC analysis.
Maintaining assay and low impurity profiles means more than controlling the reactor or filter. Calcium Pantothenate is sensitive to moisture and elevated temperature, both of which can affect chemical integrity during storage and transport. Our bulk shipments are packed in double-layer PE liners inside sturdy fiber drums or bags, preventing water ingress and physical contamination. We avoid bulk loading into tankers or silos for long transport to minimize quality risks. Sampling at dispatch and at delivery destination provides transparency and real-time data to support our claims.
Traceability is crucial. Every bulk shipment contains batch labels, shipment date, and packaging time stamped for full lot traceability from facility to end user. Our technical team is available to support customer quality audits and can provide detailed batch documentation or retention samples on request. This hands-on approach stems from years of direct dialogue with finished dosage and premix plants, whose compliance auditors insist on complete records and robust quality procedures.
We continually evaluate analytical methods and process checkpoints, drawing on feedback from our customers as well as lessons learned internally. We welcome site visits and outside audits as a way to demonstrate our ongoing commitment to product quality and supply chain transparency. With upcoming regulatory changes on elemental impurities and possible updates to monographic requirements, we invest in staff training and independent method validation to ensure we stay at the forefront of compliance and end-user trust.
In the industrial landscape, the topic of packaging size and order quantities often drifts into the background, yet for those of us who operate factories and manage production schedules, these fundamentals set the pace for efficiency, safety, and cost control. Our experience with Calcium Pantothenate production gives us a distinct view of what works best for storage, transport, and downstream customer usage. This isn’t marketing rhetoric—it comes from years of feedback, site audits, and hands-on process evaluations.
Drums and fiberboard cartons set the benchmark for most bulk shipments leaving our doors. For Calcium Pantothenate, we favor 25 kg fiber drums lined with double polyethylene bags. The 25 kg size isn’t arbitrary; it strikes a solid balance between easy handling for warehouse crews, safe stacking, and practical logistics on the customer’s floor. Our customers in both the nutrition supplement and food industries prefer drums of this size, as it fits well into typical dosing, batching, and re-packing operations. The robust design of the drums and the interior bagging maintain product quality during cross-border shipping, especially in variable climates that could otherwise encourage clumping or degradation.
Palletization plays a role here—our production and logistics team organizes outgoing orders in 25 kg drums on standard euro-pallets, typically accommodating 12 to 18 drums per pallet. This supports not only warehouse efficiency but also global container optimization, reducing unnecessary freight costs and minimizing risk during long-haul transport.
From a manufacturing perspective, we rarely entertain requests for single-drum orders. Setting the minimum order quantity at 100 kg, packed in four 25 kg drums, enables us to rationalize batching, cleaning cycles, and line start-ups. Our plant managers watch the cost and productivity figures closely; firing up an entire production line for a handful of drums leads to waste—raw material, labor, and energy—all of which pushes up costs for everyone in the chain. The 100 kg minimum also streamlines our documentation process, batch release, and compliance record-keeping. Certifications and finished goods testing consume the same resources for small and large batches, so this threshold lets us serve a broad range of clients without sacrificing product quality or delivery reliability.
Clients with larger contract quantities—those running sustained product campaigns—often take full containers, and for these partners, our sales and logistics teams build optimal shipment plans based on projected demand and warehousing capacity at their end. We regularly review these arrangements, adjusting drum counts per pallet and document flows to meet evolving customer demands, but the 25 kg drum remains a constant for reliability and consistency.
Manufacturing facilities must adhere to rules spanning food safety, environmental responsibility, and worker protection. Our drum-and-polybag system guards Calcium Pantothenate from accidental exposure to air and humidity while complying with regulatory demands for traceability and hygiene. We do not shift these standards for sub-minimum orders. Instead, our technical team provides clear guidance on storage conditions and shelf life, all detailed in our standard documentation sets. Orders requiring bespoke labelling, pallet patterns, or documentation (such as GMP, kosher, or halal certifications) fit seamlessly into our established system; years of feedback from both local and multinational customers have shaped this as the baseline—not an add-on.
Rising regulations, packaging waste concerns, and requests for smaller custom batches do challenge the traditional packaging approach. Our team remains open to re-assessing protocols when genuinely justified by volume trends or substantial process improvements. Technical teams routinely analyze package weight tolerances, material thickness, and recycling impacts. Any packaging change flows from data—trial runs and field reports guide us. We remain focused on supporting our customers’ operations with stable quality, traceable delivery, and hands-on guidance from the beginning of an order to its delivery dock.
As a manufacturer with extensive experience in pharmaceutical-grade production, our focus always starts with compliance. Current United States Pharmacopeia (USP) and European Pharmacopoeia (EP) standards set the benchmark for quality and safety in Calcium Pantothenate used for API, food, and nutraceutical applications. Our production lines stay aligned to the latest published monographs referenced by authorities worldwide. During each batch release, our quality control team validates assay, identification, impurities, loss on drying, and heavy metals using validated methods, referencing the precise requirements in the compendia.
We have invested in high-purity synthesis—a process built around consistent, reproducible controls—to support our compliance claims. Every lot sent for export or domestic sale carries a full Certificate of Analysis, matching parameters tested against USP and EP thresholds. Regulatory audits and annual reviews further strengthen our compliance record. Through open engagement with regulatory agencies, we’re able to track updates to the monographs, expeditiously reflecting those changes in our in-house specifications and documentation packages.
Transporting Calcium Pantothenate across international borders introduces another layer of complexity. As the manufacturer, we control the logistics chain, ensuring the product’s stability and integrity from our site to the final consignee. Calcium Pantothenate is classified as non-hazardous under global transport regulations, including IATA, IMDG, and ADR. This status reduces the burden for special shipping certifications or dangerous goods documentation.
Despite its non-hazardous classification, authorities in most import markets require certificates that verify the product’s status—such as the Safety Data Sheet, Certificate of Origin, and Certificate of Analysis—accompanying every consignment. Some destination countries expect compliance declarations or registration numbers if the end-use falls under pharmaceutical or food applications. Our logistics team coordinates with freight partners to manage any country-specific requirements that come up, particularly for health authority documentation requests or pre-shipment customs approvals.
We use moisture-protective, food-grade packaging—typically fiber drums with inner poly-liners—for each shipment. This protects the material from humidity, contamination, and physical damage during transit. Lot numbers, manufacturing dates, and expiry information are clearly labeled. Packaging can be tailored to meet buyer specifications or regulatory expectations, and we maintain detailed batch traceability records accessible for post-shipment audits.
Being at the factory source allows us to provide comprehensive technical files, regulatory dossiers, and answers to any compliance question within our direct control. We frequently receive audits from customers and authorities, whose expectations guide continual improvement in both process and reporting. Updates in USP and EP testing protocols reach our lab first, ensuring ongoing alignment. We do not rely on intermediaries for information or documentation; our regulatory and technical affairs teams take charge of every query or market challenge.
For questions requiring deeper technical analysis or customer audits, our manufacturing and regulatory staff support document reviews, method transfers, and on-site inspections. Our ability to adapt to evolving regulatory climates and logistics practices lies in direct control of each production and shipping step. We stand behind the full regulatory and technical pedigree of our Calcium Pantothenate, wherever it ships.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales7@bouling-chem.com, +8615371019725 or WhatsApp: +8615371019725
